Denosumab, sold under the brand name Prolia among others, is a human monoclonal antibody used for the treatment of osteoporosis, treatment-induced bone loss, metastases to bone, and giant cell tumor of bone. From Wikipedia
Investors are cautious ahead of fourth-quarter data on its experimental weight-loss drug MariTide